Infinitt debuts web-based PACS with advanced viz software

TriMed Staff | | Health Imaging | Artificial Intelligence
Infinitt will present Xelis, a new line of clinical imaging tools using volume rendering and other post-processing techniques, at the European Congress of Radiology (ECR) in Vienna, Austria this week.

The Seoul, Korea-based company developed the Xelis line of products as software modules for its web-based PACS. The product line includes Xelis Colon, Xelis Lung Solution, Xelis Cardiac, Xelis Fusion and Xelis Dental.

The advanced visualization software, which is pending CE approval, is designed for fast data loading and reconstruction of large-volume data sets, while the web-based technology allows access from Internet-connected or wireless PC, according to Infinitt.

TriMed Staff

Related Content

Experts developing AI model that learns from calcium-scoring CT scans
FDA has approved over 1,000 clinical AI applications, with most aimed at radiology
Commercially available AI increases breast cancer detection by nearly 20%
Clinicians want AI to show its work
ACR Assess-AI national data registry tracks performance of clinical algorithms
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.